Incise with enhanced acrylic and improved Stellaris system capabilities was designed to minimize posterior capsular opacification.

Two awards are being offered by CooperVision to foster exploration of technology advancement in ocular surface health and anterior segment symptomology.

This device measures light scatter, which is not measurable using traditional wavefront aberrometry.

Dr. Ben Gaddie will present Under Pressure: Glaucoma Update in the Optometry Times’ second editorial Webinar in the 2013 series.

Watch Dr. Justin Bazan and Jason Daniels debate the merits of a practice Web site or a practice social media presence

Alcon launches its new daily disposable contact lens to North American practitioners.

See what will be coming at this year’s 25th Vision Expo West show. Dr. Kirk Smick shares details.

Join Prevent Blindness America June 18 in Washington, DC, to learn more about eye and vision health.

Study shows rebamipide was more effective than sodium hyaluronate in corneal and conjunctival staining tests and was reported by patients to be more effective for relieving foregin-body sensation and eye pain.

Valeant Pharmaceuticals has entered into an agreement to acquire B+L for $8.7 billion, which includes $4.2 billion in debt. The deal is expected to close in Q3, and B+L will retain its name.

B+L subsidiary Ista pleads guilty to conspiracy charges in anti-kickback case and agrees to pay $34M in civil and criminal fines.

Study shows that patients wearing 1-Day Acuvue TruEye lenses exhibit no clinically significant differences as compared to spectacle wearers after a year of lens wear.

Study shows retinal imaging technology better detects retinal lesions compared with ophthalmoscopy.

Industry supports EyeXam mobile app to help users find local eyecare practitioners.

Senju acquired the rights to co-develop and market Allegro's integrin peptide therapy for intravitreal injection for vascular eye diseases such as AMD and diabetic macular edema.